Dr. Brock is the Principal of Brock Scientific Consulting, LLC, and serves as an adjunct associate professor of Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill. Dr. Brock has more than 35 years of experience in toxicology and served as a toxicology manager and toxicology director at DuPont, Unilever, and Otsuka. As an experienced consultant, he has provided services to pharmaceutical, food, medical equipment, chemical industry, and consumer products companies, including designing nonclinical safety study, providing toxicological position papers, assessing product risk and safety, and communication to global regulatory agencies (FDA, EMA, BfRAM, MHRA, PMDA, etc.).
Dr. Brock is a fellow of American Toxicology Society. He has published more than 50 papers and edited 9 books on toxicology and preclinical safety research. He also served as associate editor or reviewer for 3 toxicology journals. Dr. Brock has been invited to more than 40 seminars around the world.
Dr. Brock holds positions in multiple organizations, such as President of the American Board of Toxicity, Chairman of the Hazardous Air Polluting Substances (HAPS) Toxicology Committee, Chairman of the ILSI/HESI Project, etc.. Dr. Brock is serving on multiple expert groups and committees, including the International Pharmaceutical Excipient Council (IPEC), American College of Toxicology, Endowment Fund